Close Menu

cytogenetics

NEW YORK (GenomeWeb News) – Two forms of a rare subgroup of acute lymphoblastic leukemia form through chromothripsis, or catastrophic chromosome shattering, researchers from the Wellcome Trust S

The discovery of variants of unknown significance during a prenatal chromosomal microarray analysis can create headaches for genetic counselors who are used to delivering certain results to patients, according to the authors of a recent paper.

Oxford Gene Technology this week announced that it has acquired Cytocell, a supplier of probes for fluorescence in situ hybridization experiments.

NEW YORK (GenomeWeb News) – Oxford Gene Technology said today that it has acquired Cytocell for an undisclosed sum.

CombiMatrix has benefitted from new guidelines that recommend prenatal chromosomal microarray analysis as a first-line test in the case of abnormal ultrasound findings, as well as a preferred test to identify the cause of death in stillbirths.

Oxford Gene Technology announced this week that it has been awarded a tender by the UK National Health Service to supply chromosomal microarrays to four labs in Britain, with an additional eight labs able to procure arrays through an agreed-upon supply framework.

This article has been updated to include comments from Illumina and Agilent representatives.

A British effort to compare the clinical and cost effectiveness of prenatal chromosomal microarray analysis with standard karyotyping should conclude case recruitment by May 2014, with the results of the study out by January 2015, "at the latest," according to the project's lead

This article has been updated to include comments from CytoGenX.
CytoGenX, a Stony Brook, NY-based medical genetic testing services company, recently introduced chromosomal microarray analysis for a number of different indications.

There is "still a lot to like" about Affymetrix, according to Peter Lawson.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.